Since the nuclear Nrf2 stabilization result in its transcriptional activity increases in cancer cells, which contributes to tumor cell chemoresistance and proliferation [15–17], it is likely that the rise of Nrf2 activity mainly occur in more malignant undifferentiated tumor cells [30]. Here, NFE2L2 is linked to cancer.